Details for Patent: 12,662,445
✉ Email this page to a colleague
Which drugs does patent 12,662,445 protect, and when does it expire?
Patent 12,662,445 protects CUVRIOR and is included in one NDA.
This patent has forty-eight patent family members in twenty-seven countries.
Drugs Protected by US Patent 12,662,445
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orphalan | CUVRIOR | trientine tetrahydrochloride | TABLET;ORAL | 215760-001 | Apr 28, 2022 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | A METHOD FOR THE TREATMENT OF ADULT PATIENTS WITH STABLE WILSON'S DISEASE WHO ARE DE-COPPERED AND TOLERANT TO PENICILLAMINE | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,662,445
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 115080 | ⤷ Start Trial | |||
| Australia | 2019263969 | ⤷ Start Trial | |||
| Australia | 2024227767 | ⤷ Start Trial | |||
| Brazil | 112020018451 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
